| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 4.78e-12 | 11 | 96 | 6 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 8.64e-09 | 32 | 96 | 6 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 4.81e-08 | 42 | 96 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.10e-06 | 130 | 96 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | kinase binding | DAB2IP POTEE CDK5RAP3 NBEAL1 ACTBL2 ACTB ACTG1 POTEKP BCL11A TEX14 POTEI MAPK8IP2 RYR2 NIN | 2.14e-04 | 969 | 96 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | DAB2IP POTEE CDK5RAP3 NBEAL1 ACTBL2 ACTB ACTG1 POTEKP BCL11A TEX14 POTEI MAPK8IP2 RYR2 | 2.74e-04 | 873 | 96 | 13 | GO:0019901 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 6.29e-04 | 8 | 96 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP LLGL2 DOCK7 DGKI ARHGAP9 ARHGAP11A ARHGAP11B DENND3 ARHGEF10L | 7.49e-04 | 507 | 96 | 9 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP LLGL2 DOCK7 DGKI ARHGAP9 ARHGAP11A ARHGAP11B DENND3 ARHGEF10L | 7.49e-04 | 507 | 96 | 9 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.00e-03 | 10 | 96 | 2 | GO:0140999 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 5.12e-09 | 31 | 94 | 6 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.11e-08 | 35 | 94 | 6 | GO:0099188 | |
| GeneOntologyBiologicalProcess | postsynapse organization | GPHN POTEE ASIC2 ACTBL2 ACTB DOCK7 ACTG1 POTEKP POTEI ADGRL3 | 1.65e-06 | 313 | 94 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP POTEE NOG SYNE1 ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 MAPK8IP2 NIN | 1.57e-05 | 802 | 94 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP POTEE NOG SYNE1 ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 MAPK8IP2 NIN | 1.98e-05 | 819 | 94 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP POTEE NOG SYNE1 ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 MAPK8IP2 NIN | 2.17e-05 | 826 | 94 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | POTEE NOG SYNE1 ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 MAPK8IP2 NIN | 3.40e-05 | 748 | 94 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | POTEE NOG ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 NIN | 5.31e-05 | 566 | 94 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 POTEE LLGL2 CLN3 ACTBL2 PHACTR4 ACTB ACTG1 POTEKP POTEI MYO15A PARD3 RYR2 ARHGEF10L | 6.39e-05 | 912 | 94 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP GPHN POTEE ASIC2 CLN3 ACTBL2 ACTB DOCK7 ACTG1 POTEKP POTEI ADGRL3 | 6.47e-05 | 685 | 94 | 12 | GO:0050808 |
| GeneOntologyBiologicalProcess | platelet activation | 8.58e-05 | 158 | 94 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 1.23e-04 | 4 | 94 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DAB2IP PIK3CG DGKI ARHGAP9 ARHGAP11A ARHGAP11B DENND3 ARHGEF10L | 1.42e-04 | 333 | 94 | 8 | GO:0051056 |
| GeneOntologyBiologicalProcess | axon development | POTEE NOG ACTBL2 ACTB DOCK7 ACTG1 POTEKP BCL11A POTEI PARD3 NIN | 1.62e-04 | 642 | 94 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DAB2IP PIK3CG PHACTR4 DOCK7 DGKI ARHGAP9 ARHGAP11A ARHGAP11B DENND3 ARHGEF10L | 1.70e-04 | 538 | 94 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | blood coagulation | 1.88e-04 | 260 | 94 | 7 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 2.16e-04 | 266 | 94 | 7 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 2.26e-04 | 268 | 94 | 7 | GO:0007599 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.06e-10 | 32 | 96 | 7 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.06e-10 | 32 | 96 | 7 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.36e-09 | 45 | 96 | 7 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.55e-07 | 94 | 96 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.10e-07 | 104 | 96 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 7.02e-07 | 109 | 96 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | actin filament | 5.79e-05 | 146 | 96 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ACTL7B POTEE LLGL2 ACTBL2 ACTB ACTG1 ACTG2 POTEKP POTEI MYO15A DHX9 | 6.70e-05 | 576 | 96 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | POTEE CCT8L2 RPAP1 ACTBL2 EPC1 ACTB ACTG1 DGKI POTEKP POTEI CCT8L1P CEP164 DHX9 NIN | 1.37e-04 | 972 | 96 | 14 | GO:0140535 |
| GeneOntologyCellularComponent | axon | DAB2IP POTEE NOG ACTBL2 ACTB DOCK7 ACTG1 DGKI POTEKP POTEI PARD3 ADGRL3 NIN | 2.15e-04 | 891 | 96 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | dense body | 4.32e-04 | 7 | 96 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | blood microparticle | 5.35e-04 | 144 | 96 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 7.46e-04 | 155 | 96 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 9.17e-04 | 10 | 96 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 9.17e-04 | 10 | 96 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 1.12e-03 | 11 | 96 | 2 | GO:0005832 | |
| GeneOntologyCellularComponent | transferase complex | POTEE KMT2D SETD1B RPAP1 PIK3CG ACTBL2 EPC1 ACTB ACTG1 POTEKP POTEI PARD3 | 1.51e-03 | 963 | 96 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | postsynapse | GPHN PRR12 CACNA1E ASIC2 SYNE1 ACTB APBA2 ACTG1 DGKI BCL11A ADGRL3 MAPK8IP2 | 2.40e-03 | 1018 | 96 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | supramolecular fiber | POTEE CDK5RAP3 SYNE1 ACTBL2 ACTB ACTG1 ACTG2 POTEKP MTCL1 POTEI RYR2 AHNAK2 NIN | 2.82e-03 | 1179 | 96 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | POTEE CDK5RAP3 SYNE1 ACTBL2 ACTB ACTG1 ACTG2 POTEKP MTCL1 POTEI RYR2 AHNAK2 NIN | 2.99e-03 | 1187 | 96 | 13 | GO:0099081 |
| Domain | Actin_CS | 1.06e-10 | 16 | 94 | 6 | IPR004001 | |
| Domain | Actin | 1.55e-10 | 31 | 94 | 7 | IPR004000 | |
| Domain | Actin | 1.55e-10 | 31 | 94 | 7 | PF00022 | |
| Domain | ACTIN | 1.55e-10 | 31 | 94 | 7 | SM00268 | |
| Domain | ACTINS_2 | 1.64e-10 | 17 | 94 | 6 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.44e-10 | 18 | 94 | 6 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.56e-10 | 19 | 94 | 6 | PS01132 | |
| Domain | ACTINS_1 | 4.15e-08 | 8 | 94 | 4 | PS00406 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 3.24e-05 | 41 | 63 | 4 | M39655 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 5.59e-05 | 47 | 63 | 4 | M39829 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | POTEE SLC4A7 ACTB DOCK7 ACTG1 ARHGAP9 ARHGAP11A ARHGAP11B ARHGEF10L | 1.63e-04 | 450 | 63 | 9 | M27078 |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 1.95e-04 | 5 | 63 | 2 | M49034 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.13e-04 | 73 | 63 | 4 | M638 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.17e-04 | 30 | 63 | 3 | M47738 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 3.84e-04 | 77 | 63 | 4 | M41822 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 6.17e-15 | 15 | 96 | 7 | 16824795 | |
| Pubmed | 2.86e-07 | 96 | 96 | 6 | 23580065 | ||
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 4.05e-07 | 6 | 96 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 4.05e-07 | 6 | 96 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 4.05e-07 | 6 | 96 | 3 | 11709093 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 4.05e-07 | 6 | 96 | 3 | 9971772 | |
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 10049817 | ||
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 4.05e-07 | 6 | 96 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 4.05e-07 | 6 | 96 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 4.05e-07 | 6 | 96 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 4.05e-07 | 6 | 96 | 3 | 8661406 | |
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 23017337 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 4.05e-07 | 6 | 96 | 3 | 10074138 | |
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 4.05e-07 | 6 | 96 | 3 | 23875777 | |
| Pubmed | 4.05e-07 | 6 | 96 | 3 | 9841925 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 7.08e-07 | 7 | 96 | 3 | 17504171 | |
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 22535526 | ||
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 22465675 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 7.08e-07 | 7 | 96 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 7.08e-07 | 7 | 96 | 3 | 22640593 | |
| Pubmed | 1.04e-06 | 65 | 96 | 5 | 22496869 | ||
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 14694110 | ||
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 20147394 | ||
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 23260110 | ||
| Pubmed | 1.69e-06 | 9 | 96 | 3 | 16364570 | ||
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.69e-06 | 9 | 96 | 3 | 8892894 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 1.69e-06 | 9 | 96 | 3 | 10556093 | |
| Pubmed | 1.69e-06 | 9 | 96 | 3 | 18775311 | ||
| Pubmed | 1.99e-06 | 407 | 96 | 9 | 12693553 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 2.41e-06 | 10 | 96 | 3 | 1991513 | |
| Pubmed | 2.41e-06 | 10 | 96 | 3 | 23575248 | ||
| Pubmed | 2.41e-06 | 10 | 96 | 3 | 1907279 | ||
| Pubmed | 2.67e-06 | 35 | 96 | 4 | 20946988 | ||
| Pubmed | 3.31e-06 | 11 | 96 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 3.31e-06 | 11 | 96 | 3 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 3.31e-06 | 11 | 96 | 3 | 19639585 | |
| Pubmed | 3.77e-06 | 149 | 96 | 6 | 22664934 | ||
| Pubmed | 4.40e-06 | 12 | 96 | 3 | 23071112 | ||
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 17576802 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 5.71e-06 | 13 | 96 | 3 | 17920017 | |
| Pubmed | 6.19e-06 | 43 | 96 | 4 | 20876399 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 21923909 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 17411366 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 7.54e-06 | 2 | 96 | 2 | 19638415 | |
| Pubmed | A single splice site mutation in human-specific ARHGAP11B causes basal progenitor amplification. | 7.54e-06 | 2 | 96 | 2 | 27957544 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 7.54e-06 | 2 | 96 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 7.54e-06 | 2 | 96 | 2 | 22366783 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 7.54e-06 | 2 | 96 | 2 | 3335520 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9288906 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 1577857 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 38046902 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 7.54e-06 | 2 | 96 | 2 | 32588558 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30206221 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 27625340 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26583190 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32326615 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 7.54e-06 | 2 | 96 | 2 | 23756437 | |
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 7.54e-06 | 2 | 96 | 2 | 8482333 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 3221869 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29979793 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 29265728 | ||
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 7.54e-06 | 2 | 96 | 2 | 22246323 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 2837653 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 7.54e-06 | 2 | 96 | 2 | 32506774 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 2747639 | ||
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 7.54e-06 | 2 | 96 | 2 | 20847274 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21502360 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 6686106 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 213279 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33334799 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 37302068 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 37189200 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11352932 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 7.54e-06 | 2 | 96 | 2 | 21900491 | |
| Pubmed | 8.83e-06 | 100 | 96 | 5 | 21800051 | ||
| Pubmed | 9.05e-06 | 15 | 96 | 3 | 35977942 | ||
| Pubmed | 14-3-3ζ negatively regulates mitochondrial biogenesis in GBM residual cells. | 1.05e-05 | 49 | 96 | 4 | 34825085 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.07e-05 | 271 | 96 | 7 | 32433965 | |
| Pubmed | 1.35e-05 | 17 | 96 | 3 | 17360745 | ||
| Pubmed | 1.35e-05 | 17 | 96 | 3 | 8997639 | ||
| Pubmed | DAB2IP GPHN CACNA1E LSG1 SYNE1 ACTB DOCK7 DGKI MTCL1 BCL11A PARD3 MAPK8IP2 | 1.40e-05 | 963 | 96 | 12 | 28671696 | |
| Pubmed | Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. | 2.26e-05 | 3 | 96 | 2 | 9245787 | |
| Pubmed | Not just scaffolding: plectin regulates actin dynamics in cultured cells. | 2.26e-05 | 3 | 96 | 2 | 9808630 | |
| Pubmed | Impact of altered actin gene expression on vinculin, talin, cell spreading, and motility. | 2.26e-05 | 3 | 96 | 2 | 7646816 | |
| Pubmed | Molecular basis for G-actin binding to RPEL motifs from the serum response factor coactivator MAL. | 2.26e-05 | 3 | 96 | 2 | 19008859 | |
| Pubmed | Angiostatin and plasminogen share binding to endothelial cell surface actin. | 2.26e-05 | 3 | 96 | 2 | 15746964 | |
| Pubmed | Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin. | 2.26e-05 | 3 | 96 | 2 | 39195208 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31250571 | ||
| Pubmed | Actin Is Crucial for All Kinetically Distinguishable Forms of Endocytosis at Synapses. | 2.26e-05 | 3 | 96 | 2 | 27840001 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 2.26e-05 | 3 | 96 | 2 | 22403730 | |
| Pubmed | Functional molecular complexes of human N-formyl chemoattractant receptors and actin. | 2.26e-05 | 3 | 96 | 2 | 8228254 | |
| Pubmed | CTGF/Hcs24 interacts with the cytoskeletal protein actin in chondrocytes. | 2.26e-05 | 3 | 96 | 2 | 12470643 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12612070 | ||
| Pubmed | RNA helicase A acts as a bridging factor linking nuclear beta-actin with RNA polymerase II. | 2.26e-05 | 3 | 96 | 2 | 19309309 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 6865942 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17192268 | ||
| Pubmed | 2.26e-05 | 421 | 96 | 8 | 36976175 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.02e-05 | 22 | 96 | 3 | 16526095 | |
| Interaction | ACTG2 interactions | 1.11e-07 | 49 | 95 | 6 | int:ACTG2 | |
| Interaction | POTEJ interactions | 1.60e-07 | 52 | 95 | 6 | int:POTEJ | |
| Interaction | POTEI interactions | 6.46e-07 | 105 | 95 | 7 | int:POTEI | |
| Interaction | ERRFI1 interactions | 7.34e-07 | 107 | 95 | 7 | int:ERRFI1 | |
| Interaction | TWF2 interactions | 7.81e-06 | 100 | 95 | 6 | int:TWF2 | |
| Interaction | PHACTR2 interactions | 1.01e-05 | 29 | 95 | 4 | int:PHACTR2 | |
| Interaction | HSD17B3 interactions | 1.01e-05 | 29 | 95 | 4 | int:HSD17B3 | |
| Interaction | WASH8P interactions | 1.63e-05 | 11 | 95 | 3 | int:WASH8P | |
| Interaction | ARHGAP12 interactions | 1.73e-05 | 68 | 95 | 5 | int:ARHGAP12 | |
| Interaction | RNASE3 interactions | 3.56e-05 | 14 | 95 | 3 | int:RNASE3 | |
| Interaction | POTEE interactions | 4.13e-05 | 134 | 95 | 6 | int:POTEE | |
| Interaction | NAA80 interactions | 4.43e-05 | 15 | 95 | 3 | int:NAA80 | |
| Interaction | GSN interactions | 6.52e-05 | 212 | 95 | 7 | int:GSN | |
| Interaction | MAGEA10 interactions | 9.04e-05 | 50 | 95 | 4 | int:MAGEA10 | |
| Interaction | LRRC20 interactions | 9.31e-05 | 19 | 95 | 3 | int:LRRC20 | |
| Interaction | RLIM interactions | 9.78e-05 | 392 | 95 | 9 | int:RLIM | |
| Interaction | UCHL5 interactions | 1.33e-04 | 319 | 95 | 8 | int:UCHL5 | |
| Interaction | RHOT2 interactions | 1.39e-04 | 321 | 95 | 8 | int:RHOT2 | |
| Interaction | GATAD2B interactions | 1.60e-04 | 245 | 95 | 7 | int:GATAD2B | |
| Interaction | SCIN interactions | 1.62e-04 | 58 | 95 | 4 | int:SCIN | |
| Interaction | TWF1 interactions | 1.64e-04 | 172 | 95 | 6 | int:TWF1 | |
| Interaction | DEFA6 interactions | 1.68e-04 | 23 | 95 | 3 | int:DEFA6 | |
| Interaction | PHACTR4 interactions | 1.73e-04 | 110 | 95 | 5 | int:PHACTR4 | |
| Interaction | KAT14 interactions | 1.89e-04 | 112 | 95 | 5 | int:KAT14 | |
| Interaction | GC interactions | 2.10e-04 | 62 | 95 | 4 | int:GC | |
| Cytoband | 2q21.1 | 2.52e-04 | 58 | 96 | 3 | 2q21.1 | |
| Cytoband | 18p11.22 | 5.77e-04 | 17 | 96 | 2 | 18p11.22 | |
| Cytoband | 15q13.2 | 8.85e-04 | 21 | 96 | 2 | 15q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 1.24e-03 | 100 | 96 | 3 | chr15q13 | |
| Cytoband | 8q24.3 | 1.76e-03 | 113 | 96 | 3 | 8q24.3 | |
| GeneFamily | Actins | 8.40e-07 | 6 | 64 | 3 | 929 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.18e-05 | 13 | 64 | 3 | 685 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 7.36e-04 | 50 | 64 | 3 | 721 | |
| GeneFamily | UBX domain containing | 9.38e-04 | 13 | 64 | 2 | 364 | |
| GeneFamily | Ankyrin repeat domain containing | 1.65e-03 | 242 | 64 | 5 | 403 | |
| GeneFamily | PDZ domain containing | 2.06e-03 | 152 | 64 | 4 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.43e-03 | 34 | 64 | 2 | 487 | |
| GeneFamily | Actins|Deafness associated genes | 7.51e-03 | 113 | 64 | 3 | 1152 | |
| GeneFamily | EF-hand domain containing | 7.55e-03 | 219 | 64 | 4 | 863 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 7.11e-08 | 165 | 96 | 7 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-07 | 187 | 96 | 7 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.73e-07 | 188 | 96 | 7 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.86e-07 | 190 | 96 | 7 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-07 | 193 | 96 | 7 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-07 | 194 | 96 | 7 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-07 | 195 | 96 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-07 | 198 | 96 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.63e-07 | 200 | 96 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-06 | 177 | 96 | 6 | d731400997afea379f47ae8aa0f82802962b0861 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.95e-06 | 184 | 96 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.13e-06 | 186 | 96 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 186 | 96 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.33e-06 | 188 | 96 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-06 | 188 | 96 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.44e-06 | 189 | 96 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.44e-06 | 189 | 96 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 96 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 96 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 3.65e-06 | 191 | 96 | 6 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 193 | 96 | 6 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 96 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 193 | 96 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 193 | 96 | 6 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 193 | 96 | 6 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 96 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-06 | 194 | 96 | 6 | f0c113edb706d53792892115b67277a285219942 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 197 | 96 | 6 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 96 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.49e-06 | 198 | 96 | 6 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-06 | 198 | 96 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-06 | 199 | 96 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.76e-06 | 200 | 96 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.05e-06 | 123 | 96 | 5 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.56e-06 | 128 | 96 | 5 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-05 | 170 | 96 | 5 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-05 | 170 | 96 | 5 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-05 | 173 | 96 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-05 | 174 | 96 | 5 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 3.97e-05 | 176 | 96 | 5 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.07e-05 | 177 | 96 | 5 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-05 | 178 | 96 | 5 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-05 | 178 | 96 | 5 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 179 | 96 | 5 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 179 | 96 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.41e-05 | 180 | 96 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.41e-05 | 180 | 96 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.03e-05 | 185 | 96 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.03e-05 | 185 | 96 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 186 | 96 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.29e-05 | 187 | 96 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 188 | 96 | 5 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.43e-05 | 188 | 96 | 5 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.43e-05 | 188 | 96 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 5.43e-05 | 188 | 96 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.43e-05 | 188 | 96 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 5.56e-05 | 189 | 96 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 189 | 96 | 5 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.56e-05 | 189 | 96 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 189 | 96 | 5 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 189 | 96 | 5 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 189 | 96 | 5 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 5.70e-05 | 190 | 96 | 5 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 191 | 96 | 5 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 5.85e-05 | 191 | 96 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.99e-05 | 192 | 96 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 193 | 96 | 5 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 193 | 96 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 193 | 96 | 5 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 193 | 96 | 5 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 193 | 96 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 193 | 96 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 193 | 96 | 5 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 194 | 96 | 5 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.30e-05 | 194 | 96 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 194 | 96 | 5 | bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 194 | 96 | 5 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-05 | 194 | 96 | 5 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 194 | 96 | 5 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 195 | 96 | 5 | dba2a87efd7e067c094c4b367feb4138cab62735 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.45e-05 | 195 | 96 | 5 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.45e-05 | 195 | 96 | 5 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| Drug | Nsc687160 | 8.85e-09 | 18 | 94 | 5 | CID005459290 | |
| Drug | tolytoxin | 1.20e-08 | 19 | 94 | 5 | CID006440827 | |
| Drug | NSC312786 | 2.08e-08 | 21 | 94 | 5 | CID000329495 | |
| Drug | AC1L8NVR | 2.08e-08 | 21 | 94 | 5 | CID000384633 | |
| Drug | AC1Q6LQU | 4.50e-08 | 48 | 94 | 6 | CID000072380 | |
| Drug | plakin | 4.82e-08 | 82 | 94 | 7 | CID000018752 | |
| Drug | manidipine | 1.34e-07 | 95 | 94 | 7 | CID000004008 | |
| Drug | azaspiracid | 1.41e-07 | 30 | 94 | 5 | CID006451158 | |
| Drug | AC1L1HS4 | 1.99e-07 | 32 | 94 | 5 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 2.73e-07 | 34 | 94 | 5 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 2.73e-07 | 34 | 94 | 5 | CID000001312 | |
| Drug | NSC107658 | 5.54e-07 | 306 | 94 | 10 | CID000002919 | |
| Drug | B0683 | 5.59e-07 | 117 | 94 | 7 | CID006398969 | |
| Drug | epsilon-ATP | 7.18e-07 | 41 | 94 | 5 | CID000162262 | |
| Drug | m2-19 | 1.01e-06 | 19 | 94 | 4 | CID000079129 | |
| Drug | AC1L8FNU | 1.03e-06 | 44 | 94 | 5 | CID000425429 | |
| Drug | NpCaM | 1.60e-06 | 48 | 94 | 5 | CID000122259 | |
| Drug | mDia | 2.41e-06 | 93 | 94 | 6 | CID000128346 | |
| Drug | 3-methylhistidine | 3.18e-06 | 55 | 94 | 5 | CID000064969 | |
| Drug | dihydrocytochalasin B | 4.15e-06 | 58 | 94 | 5 | CID000003064 | |
| Drug | beryllium fluoride | 4.37e-06 | 103 | 94 | 6 | CID000024589 | |
| Drug | CID5288653 | 5.17e-06 | 28 | 94 | 4 | CID005288653 | |
| Drug | oryzalin | 6.27e-06 | 63 | 94 | 5 | CID000029393 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 7.05e-06 | 171 | 94 | 7 | 7535_DN | |
| Drug | AC1L1BDQ | 7.60e-06 | 173 | 94 | 7 | CID000001394 | |
| Drug | 5-IAF | 7.89e-06 | 66 | 94 | 5 | CID000123822 | |
| Drug | blebbistatin | 8.68e-06 | 116 | 94 | 6 | CID003476986 | |
| Drug | AC1L1ERT | 9.83e-06 | 69 | 94 | 5 | CID000002920 | |
| Drug | caged ATP | 1.05e-05 | 70 | 94 | 5 | CID000123806 | |
| Drug | bistheonellide A | 1.10e-05 | 11 | 94 | 3 | CID006441172 | |
| Drug | Viroisin | 1.10e-05 | 11 | 94 | 3 | CID000119538 | |
| Drug | AC1NSKFN | 1.45e-05 | 36 | 94 | 4 | CID005311324 | |
| Drug | 2C5P | 1.46e-05 | 127 | 94 | 6 | CID000447961 | |
| Drug | BFDGE | 1.46e-05 | 12 | 94 | 3 | CID000091511 | |
| Drug | microcystin-LR | 1.59e-05 | 129 | 94 | 6 | CID000445433 | |
| Drug | AC1LADJ6 | 1.67e-05 | 130 | 94 | 6 | CID000486032 | |
| Drug | sulfenosine | 1.69e-05 | 2 | 94 | 2 | CID000129862 | |
| Drug | sulfonosine | 1.69e-05 | 2 | 94 | 2 | CID000129864 | |
| Drug | AC1L9EF8 | 1.91e-05 | 79 | 94 | 5 | CID000443315 | |
| Drug | AC1OAGGW | 2.15e-05 | 203 | 94 | 7 | CID006857364 | |
| Drug | kabiramide C | 2.40e-05 | 14 | 94 | 3 | CID005288658 | |
| Drug | formamide | 2.72e-05 | 85 | 94 | 5 | CID000000713 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.88e-05 | 86 | 94 | 5 | CID000000805 | |
| Drug | polyproline | 3.07e-05 | 295 | 94 | 8 | CID000439587 | |
| Drug | Compound 1-4 | 3.26e-05 | 44 | 94 | 4 | CID005311149 | |
| Drug | Fm 4-64 | 3.59e-05 | 90 | 94 | 5 | CID002733635 | |
| Drug | AC1NRCMD | 3.59e-05 | 90 | 94 | 5 | CID005289074 | |
| Drug | AC1L22RD | 3.79e-05 | 91 | 94 | 5 | CID000065183 | |
| Drug | AC1L1IZ2 | 3.79e-05 | 304 | 94 | 8 | CID000004795 | |
| Drug | fasudil | 3.88e-05 | 151 | 94 | 6 | CID000003547 | |
| Drug | carbodiimide | 3.88e-05 | 151 | 94 | 6 | CID000009864 | |
| Drug | C18:1n-7 | 3.99e-05 | 92 | 94 | 5 | CID000122325 | |
| Drug | cnicin | 3.99e-05 | 92 | 94 | 5 | CID000091176 | |
| Drug | auxin | 4.02e-05 | 224 | 94 | 7 | CID000000801 | |
| Drug | AC1L1GXW | 4.43e-05 | 94 | 94 | 5 | CID000003891 | |
| Drug | ZnBr2 | 5.05e-05 | 3 | 94 | 2 | CID000024375 | |
| Drug | NSC3096 | 5.40e-05 | 98 | 94 | 5 | CID000002832 | |
| Drug | tetramethylrhodamine | 5.43e-05 | 50 | 94 | 4 | CID000065219 | |
| Drug | NSC106399 | 5.87e-05 | 51 | 94 | 4 | CID000002887 | |
| Drug | sulphoxide | 6.24e-05 | 101 | 94 | 5 | CID000008442 | |
| Drug | 5'IATR | 6.29e-05 | 19 | 94 | 3 | CID000074997 | |
| Drug | NSC339663 | 8.04e-05 | 250 | 94 | 7 | CID000003892 | |
| Drug | methyl vinyl ketone | 8.59e-05 | 21 | 94 | 3 | CID000006570 | |
| Drug | Mgamp-pnp | 8.59e-05 | 21 | 94 | 3 | CID005311323 | |
| Drug | BADGE | 9.75e-05 | 58 | 94 | 4 | CID000002286 | |
| Drug | methyl propynoate | 1.01e-04 | 4 | 94 | 2 | CID000013536 | |
| Drug | AC1L9STC | 1.01e-04 | 4 | 94 | 2 | CID000455431 | |
| Drug | sulfinosine | 1.01e-04 | 4 | 94 | 2 | CID000130209 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.09e-04 | 182 | 94 | 6 | 7043_UP | |
| Drug | HU-211 | 1.11e-04 | 114 | 94 | 5 | CID000107778 | |
| Drug | Aspidium | 1.16e-04 | 184 | 94 | 6 | CID000000815 | |
| Drug | K-Cl | ACTL7B CACNA1E CLN3 ACTBL2 ACTB ACTG1 ACTG2 UBXN1 MYO15A RYR2 | 1.17e-04 | 567 | 94 | 10 | CID000004873 |
| Drug | AC1NSKHI | 1.19e-04 | 61 | 94 | 4 | CID005311358 | |
| Drug | glycerophosphoinositol | 1.27e-04 | 62 | 94 | 4 | CID000167572 | |
| Drug | Nbd-Ph | 1.30e-04 | 24 | 94 | 3 | CID004682184 | |
| Drug | Pb m | 1.30e-04 | 118 | 94 | 5 | CID006327255 | |
| Drug | TCNB | 1.36e-04 | 119 | 94 | 5 | CID000008330 | |
| Drug | MAPS | 1.42e-04 | 191 | 94 | 6 | CID000066161 | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 7059_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 6757_UP | |
| Drug | AC1OAGKW | 1.51e-04 | 193 | 94 | 6 | CID006857413 | |
| Drug | nocodazole | 1.59e-04 | 477 | 94 | 9 | CID000004122 | |
| Drug | NSC3260 | 1.59e-04 | 195 | 94 | 6 | CID000220461 | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 5330_UP | |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 4106_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 3517_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 7377_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2803_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 7069_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 7138_DN | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 7352_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1838_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4773_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; HL60; HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1748_UP | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4562_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 7013_DN | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 6603_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 5433_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; HL60; HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1424_UP | |
| Drug | AC1MNW2N | 2.03e-04 | 70 | 94 | 4 | CID003359490 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.55e-11 | 8 | 93 | 5 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.55e-11 | 8 | 93 | 5 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.55e-11 | 8 | 93 | 5 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.55e-11 | 8 | 93 | 5 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 6.94e-11 | 10 | 93 | 5 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 6.94e-11 | 10 | 93 | 5 | DOID:13832 (implicated_via_orthology) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 9.83e-06 | 2 | 93 | 2 | C1855722 | |
| Disease | Baraitser-Winter syndrome | 9.83e-06 | 2 | 93 | 2 | cv:C1853623 | |
| Disease | Fryns-Aftimos Syndrome | 9.83e-06 | 2 | 93 | 2 | C1853623 | |
| Disease | cortical thickness | AKAP6 MAST4 IGHA2 ASIC2 NBEAL1 FAM178B DOCK7 DGKI C1QTNF1 TACC2 MTCL1 PARD3 DENND3 TG | 1.00e-05 | 1113 | 93 | 14 | EFO_0004840 |
| Disease | FEV/FEC ratio | AKAP6 PRR12 LLGL2 NOG RPAP1 EPC1 ASPSCR1 MTCL1 BCL11A MYO15A PARD3 DENND3 ITPK1 TG | 2.99e-05 | 1228 | 93 | 14 | EFO_0004713 |
| Disease | Uveoretinal Coloboma | 2.04e-04 | 7 | 93 | 2 | C4554007 | |
| Disease | Congenital ocular coloboma (disorder) | 3.49e-04 | 9 | 93 | 2 | C0009363 | |
| Disease | folic acid measurement | 4.17e-04 | 46 | 93 | 3 | EFO_0005111 | |
| Disease | Congenital neurologic anomalies | 4.35e-04 | 10 | 93 | 2 | C0497552 | |
| Disease | Cranioschisis | 4.35e-04 | 10 | 93 | 2 | C0265541 | |
| Disease | vital capacity | CDK5RAP3 LLGL2 NOG IPO8 SYNE1 WNT9A ACTG1 ASPSCR1 MTCL1 PARD3 C8orf34 RYR2 | 5.04e-04 | 1236 | 93 | 12 | EFO_0004312 |
| Disease | Diffuse Large B-Cell Lymphoma | 7.06e-04 | 55 | 93 | 3 | C0079744 | |
| Disease | Nonsyndromic genetic hearing loss | 1.80e-03 | 76 | 93 | 3 | cv:C5680182 | |
| Disease | alcohol consumption measurement | AKAP6 CACNA1E MAST4 CLN3 ACTG1 POU2F2 C1QTNF1 ASPSCR1 MYO15A PARD3 PHLPP2 | 1.82e-03 | 1242 | 93 | 11 | EFO_0007878 |
| Disease | Disease Exacerbation | 1.87e-03 | 165 | 93 | 4 | C0235874 | |
| Disease | Malignant neoplasm of breast | AKAP6 KMT2D LLGL2 DSC3 OTOF SYNE1 TACC2 BCL11A ARHGAP11A TREML1 | 2.06e-03 | 1074 | 93 | 10 | C0006142 |
| Disease | ICAM-1 measurement | 2.59e-03 | 24 | 93 | 2 | EFO_0004520 | |
| Disease | temperament and character inventory | 2.59e-03 | 24 | 93 | 2 | EFO_0004825 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLPVFRCEDLPDLHE | 16 | Q9H2F5 | |
| APERDTDPPLIHLDS | 56 | Q9HCE6 | |
| EPVDREPVVCHPDLE | 316 | Q9BZE9 | |
| LPEEHAVLVSDPPLS | 141 | Q9Y614 | |
| EADTPLVLPHPELEV | 1001 | Q15878 | |
| RVAPDEHPILLTEAP | 96 | Q562R1 | |
| VAPEEHPILLTEAPL | 96 | Q9BYX7 | |
| VAPEEHPVLLTEAPL | 96 | P60709 | |
| VAPEEHPVLLTEAPL | 96 | P63261 | |
| LELIHEESDAPLLPP | 1296 | Q9HAR2 | |
| ESLPILHSPDEKIPD | 426 | Q49A92 | |
| RVAPEEHPTLLTEAP | 96 | P63267 | |
| PIPEDEPSVLEAHDQ | 166 | Q99767 | |
| PALHERELDSLADLP | 1256 | Q6UB98 | |
| SLEIQHPPPLLEDEE | 631 | Q9NVE4 | |
| LPEQAEDHVPPVLRL | 21 | A6NFT4 | |
| DPESPILDLDLHLPL | 181 | A2RUS2 | |
| LQIPDPHLADPSVLE | 121 | Q16515 | |
| LLKEPHPPRLSAEEA | 2276 | Q6ZS30 | |
| LPPLDPEEIRKRLEH | 36 | Q8IY67 | |
| RELPEPILPADLHEA | 126 | Q3KRB8 | |
| ALSLDDEPEEPPAHR | 1346 | Q9Y4B5 | |
| VKEVHDELEDLPSPP | 176 | Q9NQX3 | |
| PDPPHRDRLRSKDEL | 1021 | Q5VWQ8 | |
| DDDDPEPLVAVPHRI | 301 | Q8IVH8 | |
| PLRKETEPHHELPDS | 341 | Q8IVH8 | |
| DAHPETIVLDPLPAI | 86 | Q13572 | |
| SVPLPEPLEVAHDLS | 786 | Q6P1M3 | |
| EDEDPHRPPTSEELL | 496 | Q9H089 | |
| RAPLEHRESPREPED | 901 | Q9UKN7 | |
| PSELPQLLPDLESHV | 136 | P0C870 | |
| IPRHPDELELDVDDP | 616 | Q13387 | |
| PLEAILTDDEPDHGP | 21 | Q9H165 | |
| LSTPLPEPHIDLELV | 691 | Q5VYM1 | |
| RELPPPEDDQLHSSA | 51 | Q9NVH0 | |
| VSEDHLDLLPPPEER | 121 | Q6P4F2 | |
| PLKEEEEAPLLPRTH | 56 | Q6H9L7 | |
| EEAPLLPRTHLQAEP | 61 | Q6H9L7 | |
| PHRPRLLDPDSVDDE | 66 | Q9NS61 | |
| PSHPEEPSDLEELEQ | 191 | P09086 | |
| HRLSEPPEDLDALPL | 106 | Q13421 | |
| PDISRKRRHPPDDDL | 146 | Q9P0K8 | |
| PVIPALERSLDPDLH | 61 | Q9UGQ3 | |
| EIEFPPSLDLHQEIP | 371 | Q8IZ21 | |
| VAPEEHPILLTEAPL | 796 | Q6S8J3 | |
| EELPSPPDHAERAEE | 41 | Q9BXJ1 | |
| VPLEATDSLLELPHP | 366 | Q14209 | |
| FALHPSPDEEEPIER | 236 | Q96N67 | |
| EPIERLSVPDIPKEH | 246 | Q96N67 | |
| PLPLPIRVEDENDNH | 226 | Q14574 | |
| LVPIEDIPDVHPDLQ | 196 | Q8N8A6 | |
| NLHVERNPDLPPEEL | 501 | O75912 | |
| EPSVVERPHLEELPE | 246 | Q96JB5 | |
| EEQDEELDHILSPPP | 116 | O15021 | |
| EEEREHDLPTHPRGP | 46 | Q96GL9 | |
| EVHLLPPPSEELALN | 216 | P01877 | |
| PPSDAADEEHRPLLL | 766 | Q9Y2W3 | |
| PPEEDEGTKRVDPLH | 3651 | Q92736 | |
| RHDAELRVPSPTEEP | 431 | Q6N075 | |
| FDLELVDPDTPLPHV | 461 | Q9UNU6 | |
| IEPPPLDAVIEAEHT | 821 | Q08211 | |
| LPEEETPEPTAICRH | 96 | Q3KNS1 | |
| LVPEHVETRPLLNPD | 1681 | Q9HC10 | |
| IEDDRLPVLPPHLSD | 761 | Q8TEW0 | |
| APSDNLPLVDLIEHP | 36 | Q13253 | |
| LPLVDLIEHPDPIFD | 41 | Q13253 | |
| VPPETLHIDEDDRPE | 241 | O15397 | |
| RELPEPILPADLHEA | 126 | Q6P4F7 | |
| DDIPTVVIHPPEEDL | 341 | Q9Y6M7 | |
| HIDELPPPSQELLDD | 1326 | Q8IWB6 | |
| IRLPLPDDEHDLSDR | 8211 | Q8NF91 | |
| IEPLDEEARPSHIPA | 126 | Q8N4C6 | |
| LDLDEEEVPLTPEHR | 231 | Q8IXR5 | |
| ESPRSPEEEEPHLLS | 21 | A6NM43 | |
| ESPRSPEEEEPHLLS | 21 | Q96SF2 | |
| PLSPERAPEHDLEVE | 1296 | Q9UPS6 | |
| VAPEEHPILLTEAPL | 796 | P0CG38 | |
| EDPELPDTRPLHLAK | 1536 | Q9ULL5 | |
| AHDLDVKSPPEPRSE | 346 | P57078 | |
| TELQPDVPPHERILA | 1516 | Q13023 | |
| PEADLPLPKHDLSTE | 5116 | Q8IVF2 | |
| GLEERLSPPLPHEER | 466 | Q9UPV0 | |
| GEETVPEPRLPLLDH | 16 | Q13286 | |
| EEIHVVLDTPPDPAL | 301 | P48736 | |
| EDALLLPDLSLHVPP | 266 | Q8N8E2 | |
| PRTEPCLSPEDEEHV | 46 | Q8N8Y5 | |
| SRLEPEPHEEDRTEP | 1301 | Q6ZVD8 | |
| PRHTEILTELPPLDD | 181 | Q15796 | |
| RPLPQLLDDPHEVEK | 311 | Q9BRR9 | |
| LAPEELHTDRESPRP | 1811 | O95359 | |
| PGHCLPEDEDPEERL | 81 | Q9BWH6 | |
| EEESRPPPDLARHDV | 521 | Q9BWH6 | |
| PDVDEPLETPLGHIL | 46 | Q04323 | |
| DPLPRTPELVHLDDS | 281 | O14904 | |
| RDLPPAEELPEKEHG | 261 | Q9BRR0 | |
| PEAPREVLLHPLVAE | 576 | Q86VR7 | |
| PESEEVHEPRLGELL | 46 | O75123 | |
| PAAELPLDVPHIRLD | 221 | Q86YW5 | |
| DVIPEDHRLESPTTP | 336 | Q9H3M7 | |
| RLEDIPVASLPDLHD | 1371 | P01266 | |
| SSPEIDEDRIPNPHL | 46 | Q13522 | |
| PEELHLSPQTEEPHL | 801 | O14686 |